Evaluation of Efficacy and Adverse Events After Second Immunotherapy Exposure in Endometrial and Cervical Carcinoma.

Morton, Molly; Marcu, Ioana; Levine, Monica; Cosgrove, Casey; Backes, Floor; O'Malley, David; Chambers, Laura

Morton, Molly; Marcu, Ioana; Levine, Monica; Cosgrove, Casey; Backes, Floor; O'Malley, David; Chambers, Laura.

Affiliation

Morton M; Division of Gynecologic Oncology and the Department of Obstetrics and Gynecology, The Ohio State University Wexner Medical Center, and the James Cancer Hospital and Solove Research Institute, Columbus, Ohio.

Obstet Gynecol ; 142(2): 360-363, 2023 08 01.

Article in En | MEDLINE | ID: mdl-37411031

Subject(s)

Endometrial Neoplasms; Genital Neoplasms, Female; Uterine Cervical Neoplasms; Female; Humans; Endometrial Neoplasms/drug therapy; Genital Neoplasms, Female/therapy; Immunotherapy/adverse effects; Neoplasm Recurrence, Local/drug therapy; Retrospective Studies; Uterine Cervical Neoplasms/drug therapy; Clinical Studies as Topic

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Uterine Cervical Neoplasms / Endometrial Neoplasms / Genital Neoplasms, Female Type of study: Observational_studies Limits: Female / Humans Language: En Journal: Obstet Gynecol Year: 2023 Document type: Article

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google